BR9914946A - Composição meningocócica de multicomponentes, vacina compreendendo a referida composição e respectivo processo de preparação - Google Patents
Composição meningocócica de multicomponentes, vacina compreendendo a referida composição e respectivo processo de preparaçãoInfo
- Publication number
- BR9914946A BR9914946A BR9914946-0A BR9914946A BR9914946A BR 9914946 A BR9914946 A BR 9914946A BR 9914946 A BR9914946 A BR 9914946A BR 9914946 A BR9914946 A BR 9914946A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- vaccine
- preparation process
- meningococcal
- respective preparation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 208000034762 Meningococcal Infections Diseases 0.000 abstract 1
- 108010031133 Transferrin-Binding Protein A Proteins 0.000 abstract 1
- 108010031127 Transferrin-Binding Protein B Proteins 0.000 abstract 1
- 108010062476 Transferrin-Binding Proteins Proteins 0.000 abstract 1
- 102000010912 Transferrin-Binding Proteins Human genes 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027096 gram-negative bacterial infections Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçãO MENINGOCóCICA DE MULTICOMPONENTES, VACINA COMPREENDENDO A REFERIDA COMPOSIçãO E RESPECTIVO PROCESSO DE PREPARAçãO''<D> Descreve-se uma composição contendo proteínas de ligação de transferrina A e B (TbpA e TbpB). A composição é adequada para uso em vacinas e para o tratamento de infecção bacteriana gram negativa, particularmente infecção meningocócica, demostrando um amplo espectro de proteção para inúmeros patógenos bacterianos diferentes. Também são descritas composições compreendendo Tbp's e outros componentes, tais como vesículas de membranas externas neisseriais e Cu, Zn-Superóxido Dismutase. Processos para preparação dessas composições e seus usos em vacinação contra doenças são adicionalmente fornecidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823978.3A GB9823978D0 (en) | 1998-11-02 | 1998-11-02 | Multicomponent meningococcal vaccine |
PCT/GB1999/003626 WO2000025811A2 (en) | 1998-11-02 | 1999-11-02 | Multicomponent meningococcal vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9914946A true BR9914946A (pt) | 2001-07-10 |
Family
ID=10841713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9914946-0A BR9914946A (pt) | 1998-11-02 | 1999-11-02 | Composição meningocócica de multicomponentes, vacina compreendendo a referida composição e respectivo processo de preparação |
Country Status (13)
Country | Link |
---|---|
US (2) | US6821521B1 (pt) |
EP (3) | EP1297844A3 (pt) |
JP (2) | JP2002528515A (pt) |
AT (1) | ATE242640T1 (pt) |
AU (1) | AU760858B2 (pt) |
BR (1) | BR9914946A (pt) |
CA (1) | CA2349331A1 (pt) |
DE (1) | DE69908805T3 (pt) |
DK (1) | DK1126874T5 (pt) |
ES (1) | ES2197688T5 (pt) |
GB (1) | GB9823978D0 (pt) |
PT (1) | PT1126874E (pt) |
WO (1) | WO2000025811A2 (pt) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
US20030215469A1 (en) * | 1998-11-02 | 2003-11-20 | Microbiological Research Authority | Multicomponent meningococcal vaccine |
US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
US7081244B2 (en) | 1999-02-22 | 2006-07-25 | Health Protection Agency | Neisserial vaccine compositions and methods |
DK1154791T3 (da) * | 1999-02-22 | 2008-06-16 | Health Prot Agency | Neisseria-vaccinesammensætninger og fremgangsmåder |
CA2929348A1 (en) | 1999-05-19 | 2000-11-30 | Novartis Vaccines And Diagnostics S.R.L. | Combination neisserial compositions |
RU2279889C2 (ru) * | 2000-01-17 | 2006-07-20 | Чирон С.Р.Л. | ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В |
EP1322328B1 (en) | 2000-07-27 | 2014-08-20 | Children's Hospital & Research Center at Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB0130123D0 (en) | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
EP1961427A3 (en) | 2002-08-02 | 2009-11-04 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
DE60335477D1 (de) | 2002-10-11 | 2011-02-03 | Novartis Vaccines & Diagnostic | Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien |
AU2003288660A1 (en) | 2002-11-15 | 2004-06-15 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
EP2172213B1 (en) | 2003-01-30 | 2013-04-03 | Novartis AG | Injectable vaccines against multiple meningococcal serogroups |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
CU23377A1 (es) * | 2003-11-04 | 2009-05-28 | Ct De Ingenieria Genetica Y Biotecnologia | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
JP4993750B2 (ja) | 2005-01-27 | 2012-08-08 | チルドレンズ ホスピタル アンド リサーチ センター アット オークランド | 髄膜炎菌に起因する疾患に対する広域防御のための、gna1870を基にした小胞ワクチン |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
US7853431B2 (en) | 2006-09-29 | 2010-12-14 | Fisher-Rosemount Systems, Inc. | On-line monitoring and diagnostics of a process using multivariate statistical analysis |
US7378713B2 (en) * | 2006-10-25 | 2008-05-27 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor devices with dual-metal gate structures and fabrication methods thereof |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
EP2200642B1 (en) | 2007-10-19 | 2012-04-18 | Novartis AG | Meningococcal vaccine formulations |
AU2009215364B2 (en) | 2008-02-21 | 2014-09-18 | Glaxosmithkline Biologicals S.A. | Meningococcal fHBP polypeptides |
MY150481A (en) | 2008-03-03 | 2014-01-30 | Irm Llc | Compounds and compositions as tlr activity modulators |
AU2009262893B2 (en) * | 2008-05-30 | 2015-05-21 | The U.S.A., as represented by The Secretary of the Army, on behalf of Walter Reed Army Institute Of Research | Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
EP2367568A2 (en) | 2008-12-17 | 2011-09-28 | Novartis AG | Meningococcal vaccines including hemoglobin receptor |
CA2761916A1 (fr) | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif |
US20120156281A1 (en) * | 2009-05-14 | 2012-06-21 | Sanofi Pasteur | Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein |
US9517263B2 (en) | 2009-06-10 | 2016-12-13 | Glaxosmithkline Biologicals Sa | Benzonaphthyridine-containing vaccines |
CA2772103A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
AU2010288240B2 (en) | 2009-08-27 | 2014-03-27 | Novartis Ag | Hybrid polypeptides including meningococcal fHBP sequences |
ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
GB0916557D0 (en) | 2009-09-21 | 2009-10-28 | Health Prot Agency | Commensal neisserial stress protein complexes |
CN102724988B (zh) | 2009-09-30 | 2014-09-10 | 诺华股份有限公司 | 脑膜炎球菌fHBP多肽的表达 |
JP5960055B2 (ja) | 2009-10-27 | 2016-08-02 | ノバルティス アーゲー | 改変髄膜炎菌fHBPポリペプチド |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
SG181712A1 (en) | 2009-12-15 | 2012-07-30 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
CN102869378A (zh) | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
CA2793510A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
CA2792938C (en) | 2010-03-23 | 2018-07-31 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
WO2012038801A1 (en) | 2010-09-21 | 2012-03-29 | National Institute Of Immunology | A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles |
US20150147356A1 (en) | 2011-05-12 | 2015-05-28 | Alan Kimura | Antipyretics to enhance tolerability of vesicle-based vaccines |
GB201110980D0 (en) | 2011-06-28 | 2011-08-10 | Health Prot Agency | Neisserial compositions and expression constructs |
RU2014135522A (ru) | 2012-02-02 | 2016-03-27 | Новартис Аг | Промоторы для увеличенной экспрессии белка у менингококка |
JP2015524418A (ja) | 2012-07-27 | 2015-08-24 | アンスティテュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 血管内皮細胞への髄膜炎菌の線毛媒介接着の受容体としてのcd147 |
AU2013311702A1 (en) | 2012-09-06 | 2015-02-19 | Novartis Ag | Combination vaccines with serogroup B meningococcus and D/T/P |
CA2940447C (en) | 2014-02-28 | 2023-07-11 | Glaxosmithkline Biologicals Sa | Modified meningococcal fhbp polypeptides |
CN107847532A (zh) * | 2015-06-02 | 2018-03-27 | 由卫生福利和体育大臣代表的荷兰王国 | 革兰氏阴性菌外膜囊泡抗原表面展示 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
AU640118B2 (en) * | 1988-12-19 | 1993-08-19 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Meningococcal class 1 outer-membrane protein vaccine |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
US5292869A (en) | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
FR2682041B1 (fr) | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
NL9201716A (nl) * | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
US6287574B1 (en) * | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
US6180111B1 (en) | 1995-05-18 | 2001-01-30 | University Of Maryland | Vaccine delivery system |
US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
GB9711964D0 (en) | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
AU748973B2 (en) * | 1997-07-17 | 2002-06-13 | Baxter Healthcare Sa | Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide |
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
US10967045B2 (en) * | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
CA2929348A1 (en) * | 1999-05-19 | 2000-11-30 | Novartis Vaccines And Diagnostics S.R.L. | Combination neisserial compositions |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
RU2279889C2 (ru) * | 2000-01-17 | 2006-07-20 | Чирон С.Р.Л. | ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В |
EP1322328B1 (en) * | 2000-07-27 | 2014-08-20 | Children's Hospital & Research Center at Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
EP1961427A3 (en) * | 2002-08-02 | 2009-11-04 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
AU2003288660A1 (en) * | 2002-11-15 | 2004-06-15 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
US20090035328A1 (en) * | 2007-08-02 | 2009-02-05 | Dan Granoff | fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS |
-
1998
- 1998-11-02 GB GBGB9823978.3A patent/GB9823978D0/en not_active Ceased
-
1999
- 1999-11-02 EP EP02025569A patent/EP1297844A3/en not_active Withdrawn
- 1999-11-02 WO PCT/GB1999/003626 patent/WO2000025811A2/en active IP Right Grant
- 1999-11-02 AU AU10569/00A patent/AU760858B2/en not_active Expired
- 1999-11-02 EP EP99954130A patent/EP1126874B2/en not_active Expired - Lifetime
- 1999-11-02 AT AT99954130T patent/ATE242640T1/de active
- 1999-11-02 PT PT99954130T patent/PT1126874E/pt unknown
- 1999-11-02 DK DK99954130T patent/DK1126874T5/da active
- 1999-11-02 BR BR9914946-0A patent/BR9914946A/pt not_active Application Discontinuation
- 1999-11-02 CA CA002349331A patent/CA2349331A1/en not_active Abandoned
- 1999-11-02 DE DE69908805T patent/DE69908805T3/de not_active Expired - Lifetime
- 1999-11-02 US US09/830,854 patent/US6821521B1/en not_active Expired - Fee Related
- 1999-11-02 JP JP2000579250A patent/JP2002528515A/ja active Pending
- 1999-11-02 EP EP10171629A patent/EP2248535A1/en not_active Ceased
- 1999-11-02 ES ES99954130T patent/ES2197688T5/es not_active Expired - Lifetime
-
2008
- 2008-10-20 US US12/289,098 patent/US20090148469A1/en not_active Abandoned
-
2011
- 2011-10-14 JP JP2011227284A patent/JP2012025774A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1297844A2 (en) | 2003-04-02 |
GB9823978D0 (en) | 1998-12-30 |
EP1126874B2 (en) | 2008-06-25 |
WO2000025811A3 (en) | 2000-10-05 |
DK1126874T5 (da) | 2008-12-01 |
DE69908805T3 (de) | 2008-12-24 |
CA2349331A1 (en) | 2000-05-11 |
EP1126874A2 (en) | 2001-08-29 |
JP2002528515A (ja) | 2002-09-03 |
PT1126874E (pt) | 2003-10-31 |
ES2197688T5 (es) | 2008-12-16 |
US20090148469A1 (en) | 2009-06-11 |
AU1056900A (en) | 2000-05-22 |
JP2012025774A (ja) | 2012-02-09 |
EP1297844A3 (en) | 2004-01-14 |
WO2000025811A2 (en) | 2000-05-11 |
DE69908805T2 (de) | 2004-05-19 |
DE69908805D1 (de) | 2003-07-17 |
AU760858B2 (en) | 2003-05-22 |
DK1126874T3 (da) | 2003-09-29 |
ES2197688T3 (es) | 2004-01-01 |
US6821521B1 (en) | 2004-11-23 |
ATE242640T1 (de) | 2003-06-15 |
DK1126874T4 (da) | 2008-10-13 |
EP2248535A1 (en) | 2010-11-10 |
EP1126874B1 (en) | 2003-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9914946A (pt) | Composição meningocócica de multicomponentes, vacina compreendendo a referida composição e respectivo processo de preparação | |
ATE276758T1 (de) | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid | |
TW226333B (pt) | ||
BRPI0412273A (pt) | material de zeólito, método de preparação do mesmo, preparação farmacêutica, uso de um material de zeólito, artigo médico, produto cosmético e/ou de higiene pessoal, e, métodos de liberação de óxido nìtrico, e de tratamento ou profilaxia de um indivìduo em necessidade do mesmo | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
BR9810745A (pt) | Derivados de benzimidazol | |
SI1644009T1 (en) | COMPOSITION TO INCREASE TELECOMMUNICATION ACTIVITY AND TREATMENT OF HIV INFECTION | |
BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
UA29429C2 (uk) | Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини | |
HK1065074A1 (en) | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells | |
BRPI0622298A8 (pt) | Oligorribonucleotídeo para estimular a produção de uma citocina pró-inflamatória, uso do mesmo e composição contendo tal oligorribonucleotídeo | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
WO2004071426A3 (en) | Compounds for the treatment of viral infection | |
HK1037639A1 (en) | Particles of hcv envelope proteins: use for vaccination hcv. | |
HUP0402259A2 (hu) | Vakcinák | |
AU8180001A (en) | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells | |
FI961536A (fi) | Menetelmä virusten inaktivoimiseksi polyalkeeniglykolin läsnäollessa samoin kuin siten saatu farmaseuttinen valmiste | |
NO20051561L (no) | Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. | |
AR005750A1 (es) | Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion | |
MX9805441A (es) | Compuestos terapeuticos. | |
IL115074A0 (en) | A novel salt of (1s,4r)-cis-4--Ú2-amino-6-(cyclopropylamino)-9h-purin-9-yl-¾- 2-cyclopentene-1-methanol solvates thereof their preparation and pharmaceutical compositions containing them | |
DE60140950D1 (de) | Neuer gentherapeutischer wirkstoff zur behandlung g | |
BR0007966A (pt) | Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana | |
DE69511247D1 (de) | Therapeutische benzonitrile | |
BR9710824A (pt) | Processo para produção da proteìna gp160 recombinante e da proteina gp160 recombinante do vìrus da imunodeficiência humana. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: HEALTH PROTECTION AGENCY (UK) Free format text: TRANSFERIDO DE: MICROBIOLOGICAL RESEARCH AUTHORITY CAMR |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: THE SECRETARY OF STATE FOR HEALTH (GB) |